Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
| Weiss Ratings | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -14.33 | |||
| Price History | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -100.00% | |||
| 30-Day Total Return | -100.00% | |||
| 60-Day Total Return | -100.00% | |||
| 90-Day Total Return | -100.00% | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 07, 2024 | |||
| 52-Week High Price (Date) | Mar 07, 2024 | |||
| Valuation | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -100.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | -- | |||
| Dividends and Shares | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 31.40B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 855 1626 | |||
| Address | 477 South Rosemary Avenue West Palm Beach, FL 33401 | |||
| Website | www.rennovahealth.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 17.95% | |||
| Profit Margin | 11.59% | |||
| Management Effectiveness | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 11.35% | |||
| Return on Equity | -- | |||
| Income Statement | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 20.30M | |||
| Total Revenue (TTM) | 20.30M | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 12.81M | |||
| EBITDA (TTM) | 4.01M | |||
| EBIT (TTM) | 3.65M | |||
| Net Income (TTM) | 2.36M | |||
| Net Income Avl. to Common (TTM) | 2.36M | |||
| Total Revenue Growth (Q YOY) | 25.20% | |||
| Earnings Growth (Q YOY) | 58.58% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 100.00% | |||
| Balance Sheet | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 123.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 5.68M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -27.57M | |||
| Current Ratio (Q) | 0.120 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 19.85M | |||
| Total Current Liabilities (Q) | 47.19M | |||
| Total Debt (Q) | 12.24M | |||
| Total Liabilities (Q) | 47.41M | |||
| Total Common Equity (Q) | -27.56M | |||
| Cash Flow | RNVA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.08M | |||
| Cash from Financing (TTM) | -1.13M | |||
| Net Change in Cash (TTM) | -361.30K | |||
| Levered Free Cash Flow (TTM) | -27.40K | |||
| Cash from Operations (TTM) | 1.84M | |||
